Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 4 Option exercise Director acquired 11,041 shares (option exercise)
  2. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at $38.48 ($231,546)
  3. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at $38.47 ($192,342)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 13,000 shares at $46.67 ($606,719)
  7. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $50.35 ($303,003)
  8. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $50.35 ($251,754)
  9. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $58.58 ($352,551)
  10. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $58.59 ($292,931)
  11. 4 Planned sale Director sold 158,795 shares at $60.21 ($9,561,587)
  12. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $52.64 ($316,780)
  13. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $52.67 ($263,373)
  14. 4 Planned sale Director sold 10,000 shares at an average $50.49 ($504,903)
  15. 4 Open-market sale 10% owner sold 860,123 shares at an average $45.36 ($39,014,046)
  16. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $43.80 ($263,577)
  17. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $43.80 ($219,017)
  18. 4 Open-market sale 10% owner sold 281,408 shares at $45.02 ($12,668,988)
  19. 4 Planned sale Director sold 10,000 shares at an average $34.54 ($345,351)
  20. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $39.79 ($198,971)

Page 1 of 20 · 382 filings